As of Oct 24
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 7.50 and a low estimate of 7.50. The median estimate represents a +89.88% increase from the last price of 3.95.
The current consensus among 1 polled investment analysts is to Hold stock in NovaBay Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.